Drug interaction classified as: synergy
Source: DDInter
Antiarrhythmic · Treatment for Lambert-Eaton myasthenic syndrome
Amifampridine blocks nerve terminal potassium channels. This action prolongs the action potential duration at the nerve terminal, leading to increased calcium influx. The increased intracellular calcium then enhances transmitter (acetylcholine) release.
l BREAST FEEDING
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
8 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: BNF·Verified: 2026-05-13 · House clinical team